Cargando…
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation
PURPOSE OF REVIEW: The purpose of this review is to summarize the epidemiology, mechanisms, and management of cardiovascular complications of Bruton’s Tyrosine Kinase inhibitors (BTKIs). RECENT FINDINGS: Ibrutinib increases the risk of atrial fibrillation, bleeding, and hypertension compared with no...
Autores principales: | Sestier, Maude, Hillis, Christopher, Fraser, Graeme, Leong, Darryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330192/ https://www.ncbi.nlm.nih.gov/pubmed/34342738 http://dx.doi.org/10.1007/s11912-021-01102-1 |
Ejemplares similares
-
Cardiotoxicity of Immune Checkpoint Inhibitors
por: Patel, Rushin P., et al.
Publicado: (2021) -
Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues
por: Bracun, Valentina, et al.
Publicado: (2020) -
The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population
por: Asokan, Ishan, et al.
Publicado: (2020) -
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building
por: Sadler, Diego, et al.
Publicado: (2021) -
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications
por: Cuomo, Alessandra, et al.
Publicado: (2020)